特朗普提名的美国食品药品监督管理局（FDA）代理人海蒂·奥弗顿在参议院确认听证会上表示，麻疹、腮腺炎和风疹疫苗（MMR）"是安全有效的，是我们目前应对麻疹疫情的最佳工具"2。这一立场与特朗普数周前暗示该疫苗可能"相当致命"的说法形成鲜明对比2。参议院小组就奥弗顿在堕胎药物获取、疫苗安全性和食品安全等议题上的立场进行了质询13。
在听证会期间，奥弗顿在多位参议员的追问下重申"美国市场上现在的每种疫苗根据FDA的标准都是安全有效的"2。参议员比尔·卡西迪曾批评奥弗顿在特朗普8月疫苗行政令中的角色"几乎不合格"2。奥弗顿同时承诺，如总统要求她打破疫苗安全保证，她会提供最佳建议并遵循FDA的法定要求2。
现年37岁的奥弗顿若获确认，将成为美国历史上最年轻的FDA专员2。目前美国正经历自1991年以来最高的麻疹病例数2，而FDA在2025年的裁员计划将劳动力削减近20%2。
Trump's nominee for FDA commissioner, Heidi Oveerton, appeared before the Senate for her confirmation hearing, where she addressed contentious questions about her positions on abortion medication access, vaccine safety, and food safety regulations 13. At the center of the hearing was a notable divergence between Oveerton's stance and President Trump's earlier comments regarding measles vaccines.
During the hearing, Oveerton stated that the MMR vaccine is "safe and effective" and represents "our best tool right now for addressing measles" 2. She further affirmed that "every vaccine currently on the market in the United States meets FDA standards for safety and effectiveness" 2. This position directly contradicts Trump's recent suggestion that the MMR vaccine might be "quite deadly" 2. Senator Bill Cassidy previously characterized Oveerton's role in Trump's August vaccine executive order as "barely qualified" 2.
The United States is currently experiencing its highest number of measles cases since 1991 2. If confirmed, the 37-year-old Oveerton would become the youngest FDA commissioner in American history 2. During questioning from senators, Oveerton pledged that if the president asked her to compromise on vaccine safety assurances, she would provide her best advice and adhere to the FDA's legal obligations 2. The hearing also addressed broader concerns about the agency's capacity, as the FDA is slated to reduce its workforce by nearly 20 percent in 2025 2.
评论
还没有评论，欢迎留下第一条。